• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结构与功能分析 Ccr1l1,一种仅在啮齿动物中表达的嗜酸性粒细胞选择性趋化因子受体同源物。

Structural and functional analysis of Ccr1l1, a Rodentia-restricted eosinophil-selective chemokine receptor homologue.

机构信息

Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

出版信息

J Biol Chem. 2021 Jan-Jun;296:100373. doi: 10.1016/j.jbc.2021.100373. Epub 2021 Feb 3.

DOI:10.1016/j.jbc.2021.100373
PMID:33548230
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7949164/
Abstract

Mouse Ccr1l1 (Ccr1-like 1) encodes an orphan G-protein-coupled receptor (GPCR) with the highest homology to the inflammatory and highly promiscuous chemokine receptors Ccr1 and Ccr3 (70 and 50% amino acid identity, respectively). Ccr1l1 was first cloned in 1995, yet current knowledge of this putative chemokine receptor is limited to its gene organization and chromosomal localization. Here we report that Ccr1l1 is a Rodentia-specific gene selectively expressed in eosinophils. However, eosinophil phenotypes, development, and responsiveness to chemokines were all normal in naïve Ccr1l1 knockout mice. We demonstrate for the first time that recombinant Ccr1l1 is expressed on the plasma membrane of transfected cells and contains an extracellular N terminus and an intracellular C terminus, consistent with GPCR topology. Using receptor internalization, β-arrestin recruitment, calcium flux, and chemotaxis assays, we excluded all 37 available mouse chemokines, including Ccr1 ligands, and two viral chemokines as Ccr1l1 ligands, and demonstrated that mouse Ccr1, but not Ccr1l1, exhibits constitutive signaling activity. However, sequence analysis and structural modeling revealed that Ccr1l1 is well equipped to act as a classical signaling GPCR, with N-terminal sulfotyrosines as the only signaling and chemokine-binding determinant absent in Ccr1l1. Hereof, we show that a sulfatable N-terminal Ccr1 Y residue is essential for chemotaxis and calcium responses induced by Ccl3 and Ccl9/10, but substituting the corresponding Ccr1l1 F residue with tyrosine failed to confer responsiveness to Ccr1 ligands. Although Ccr1l1 remains an extreme outlier in the chemokine receptor family, our study supports that it might respond to unidentified mouse chemokine ligands in eosinophil-driven immune responses.

摘要

鼠 Ccr1l1(Ccr1 样 1)编码孤儿 G 蛋白偶联受体(GPCR),与炎症和高度混杂的趋化因子受体 Ccr1 和 Ccr3 的同源性最高(分别为 70%和 50%的氨基酸同一性)。Ccr1l1 于 1995 年首次克隆,但目前对这种假定的趋化因子受体的了解仅限于其基因组织和染色体定位。在这里,我们报告 Ccr1l1 是一种仅在嗜酸性粒细胞中选择性表达的啮齿动物特异性基因。然而,在没有 Ccr1l1 基因敲除的小鼠中,嗜酸性粒细胞表型、发育和对趋化因子的反应均正常。我们首次证明重组 Ccr1l1 表达在转染细胞的质膜上,并且含有细胞外 N 端和细胞内 C 端,符合 GPCR 拓扑结构。通过受体内化、β-抑制蛋白募集、钙流和趋化性测定,我们排除了所有 37 种可用的小鼠趋化因子,包括 Ccr1 配体,以及两种病毒趋化因子作为 Ccr1l1 配体,并证明了小鼠 Ccr1,但不是 Ccr1l1,具有组成型信号活性。然而,序列分析和结构建模表明,Ccr1l1 具有作为经典信号 GPCR 的充分装备,其 N 端磺基酪氨酸是 Ccr1l1 中缺失的唯一信号和趋化因子结合决定因素。因此,我们表明 Ccr1 的 N 端 Cys 残基是 Ccl3 和 Ccl9/10 诱导的趋化和钙反应所必需的,但用酪氨酸取代相应的 Ccr1l1 F 残基未能赋予对 Ccr1 配体的反应性。尽管 Ccr1l1 在趋化因子受体家族中仍然是一个极端的异类,但我们的研究支持它可能对嗜酸性粒细胞驱动的免疫反应中的未识别的小鼠趋化因子配体做出反应。

相似文献

1
Structural and functional analysis of Ccr1l1, a Rodentia-restricted eosinophil-selective chemokine receptor homologue.结构与功能分析 Ccr1l1,一种仅在啮齿动物中表达的嗜酸性粒细胞选择性趋化因子受体同源物。
J Biol Chem. 2021 Jan-Jun;296:100373. doi: 10.1016/j.jbc.2021.100373. Epub 2021 Feb 3.
2
Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner.巨噬细胞衍生趋化因子以不依赖CC趋化因子受体3和CC趋化因子受体4的方式诱导人嗜酸性粒细胞趋化。
J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):527-32. doi: 10.1016/s0091-6749(99)70481-1.
3
Influence of Chemokine N-Terminal Modification on Biased Agonism at the Chemokine Receptor CCR1.趋化因子 N 端修饰对趋化因子受体 CCR1 偏激动效应的影响。
Int J Mol Sci. 2019 May 15;20(10):2417. doi: 10.3390/ijms20102417.
4
The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation.趋化因子受体CCR1和CCR3的N端细胞外区域分别是MIP-1α和嗜酸性粒细胞趋化因子结合的决定因素,但第二个结构域对于有效的受体激活至关重要。
J Biol Chem. 1998 Aug 7;273(32):19972-6. doi: 10.1074/jbc.273.32.19972.
5
The chemokine receptor CCR1 is constitutively active, which leads to G protein-independent, β-arrestin-mediated internalization.趋化因子受体 CCR1 持续激活,导致 G 蛋白非依赖性、β-arrestin 介导的内化。
J Biol Chem. 2013 Nov 8;288(45):32194-32210. doi: 10.1074/jbc.M113.503797. Epub 2013 Sep 20.
6
CC chemokine receptors 1 and 3 are differentially regulated by IL-5 during maturation of eosinophilic HL-60 cells.在嗜酸性粒细胞性HL-60细胞成熟过程中,CC趋化因子受体1和3受白细胞介素-5的调控存在差异。
J Immunol. 1998 Feb 1;160(3):1385-92.
7
Functional analysis of chemically synthesized derivatives of the human CC chemokine CCL15/HCC-2, a high affinity CCR1 ligand.人CC趋化因子CCL15/HCC-2(一种高亲和力CCR1配体)化学合成衍生物的功能分析
J Pept Res. 2004 Jan;63(1):36-47. doi: 10.1046/j.1399-3011.2004.00102.x.
8
Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways.CC趋化因子受体1调控通路的差异趋化因子激活:Gα14偶联通路的配体选择性激活
Eur J Immunol. 2004 Mar;34(3):785-795. doi: 10.1002/eji.200324166.
9
Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo.豚鼠嗜酸性粒细胞趋化因子受体C-C趋化因子受体-3的克隆与特性分析:体内使用单克隆抗体进行阻断
J Immunol. 1998 Dec 1;161(11):6139-47.
10
Variations in eosinophil chemokine responses: an investigation of CCR1 and CCR3 function, expression in atopy, and identification of a functional CCR1 promoter.嗜酸性粒细胞趋化因子反应的变异:CCR1和CCR3功能、在特应性中的表达研究以及功能性CCR1启动子的鉴定
J Immunol. 2003 Jun 15;170(12):6190-201. doi: 10.4049/jimmunol.170.12.6190.

本文引用的文献

1
Functional anatomy of the full-length CXCR4-CXCL12 complex systematically dissected by quantitative model-guided mutagenesis.定量模型指导下的突变分析系统解析全长 CXCR4-CXCL12 复合物的功能解剖结构。
Sci Signal. 2020 Jul 14;13(640):eaay5024. doi: 10.1126/scisignal.aay5024.
2
Structural basis for chemokine receptor CCR6 activation by the endogenous protein ligand CCL20.化学趋化因子受体 CCR6 被内源性蛋白配体 CCL20 激活的结构基础。
Nat Commun. 2020 Jun 15;11(1):3031. doi: 10.1038/s41467-020-16820-6.
3
Crosslinking-guided geometry of a complete CXC receptor-chemokine complex and the basis of chemokine subfamily selectivity.
交联引导的完整 CXC 受体-趋化因子复合物的结构及其趋化因子亚家族选择性的基础。
PLoS Biol. 2020 Apr 9;18(4):e3000656. doi: 10.1371/journal.pbio.3000656. eCollection 2020 Apr.
4
Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding.CXCL12 与非典型趋化因子受体 3 结合的动力学揭示了受体 N 端在趋化因子结合中的作用。
Sci Signal. 2019 Sep 10;12(598):eaaw3657. doi: 10.1126/scisignal.aaw3657.
5
Chemokine Subversion by Human Herpesviruses.人疱疹病毒对趋化因子的颠覆作用。
J Innate Immun. 2018;10(5-6):465-478. doi: 10.1159/000492161. Epub 2018 Aug 30.
6
CXCL4/Platelet Factor 4 is an agonist of CCR1 and drives human monocyte migration.趋化因子 CXCL4/血小板因子 4 是 CCR1 的激动剂,可驱动人单核细胞迁移。
Sci Rep. 2018 Jun 21;8(1):9466. doi: 10.1038/s41598-018-27710-9.
7
Remodeling our concept of chemokine receptor function: From monomers to oligomers.重塑我们对趋化因子受体功能的认识:从单体到寡聚体。
J Leukoc Biol. 2018 Aug;104(2):323-331. doi: 10.1002/JLB.2MR1217-503R. Epub 2018 May 2.
8
New insights in chemokine signaling.趋化因子信号传导的新见解。
F1000Res. 2018 Jan 23;7:95. doi: 10.12688/f1000research.13130.1. eCollection 2018.
9
Chemokines in homeostasis and diseases.趋化因子在稳态和疾病中的作用。
Cell Mol Immunol. 2018 Apr;15(4):324-334. doi: 10.1038/cmi.2017.134. Epub 2018 Jan 29.
10
Elevating adipose eosinophils in obese mice to physiologically normal levels does not rescue metabolic impairments.将肥胖小鼠的脂肪嗜酸性粒细胞提升至生理正常水平并不能挽救代谢损伤。
Mol Metab. 2018 Feb;8:86-95. doi: 10.1016/j.molmet.2017.12.004. Epub 2017 Dec 16.